Loading patent…
AssigneeLupin Limited
InventorsGirij Pal Singh, Radhakrishna Bhikaji Shivdavkar, Govind Dnyanoba Ausekar, Mithun Dasharath Surwase, Rajendra Somnath Mhaske, Suhas Ganpat Tambe
Estimating the term…
A precipitation process for amorphous Letermovir according to Formula-I, contains residual solvents in accordance with ICH guidelines and is suitable for the preparation of orally administered pharmaceutical formulations. The formulations of the amorphous Letermovir are intended for use in methods of prophylaxis or methods of treatment of viral diseases, in particular human cytomegalovirus (HCMV) infections.
A precipitation process for isolating amorphous Letermovir according to Formula-I,
A precipitation process for isolating amorphous Letermovir according to Formula-I, comprises:
3-11. (canceled)
Dependencies are inferred from the claim text.